Inhibition of dipeptidyl peptidase IV by novel inhibitors with pyrazolidine scaffold

This publication has 12 references indexed in Scilit:

• Synthesis and evaluation of pyrazolidine derivatives as dipeptidyl peptidase IV (DP-IV) inhibitors
  Bioorganic & Medicinal Chemistry Letters, 2005
• Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus
  Current Opinion in Pharmacology, 2004
• Inhibition of Dipeptidyl Peptidase IV Improves Metabolic Control Over a 4-Week Study Period in Type 2 Diabetes
  Diabetes Care, 2002
• Improved Glucose Tolerance via Enhanced Glucose-Dependent Insulin Secretion in Dipeptidyl Peptidase IV-Deficient Fischer Rats
  Biochemical and Biophysical Research Communications, 2001
• Minireview: The Glucagon-Like Peptides
  Endocrinology, 2001
• Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26
  Proceedings of the National Academy of Sciences, 2000
• Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides
  Published by Elsevier ,1999
• Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes.
  Diabetes, 1998
• Dipeptidyl‐peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon‐like peptide‐1(7–36)amide, peptide histidine methionine and is responsible for their degradation in human serum
  European Journal of Biochemistry, 1993
• Changes of Proliferative Activity and Phenotypes in Spontaneous Differentiation of a Colon Cancer Cell Line
  Japanese Journal of Cancer Research, 1993